Mid-market private equity firm Palatine has completed its sale of Veincentre to CBPE Capital (CBPE). Financial details of the transaction have not been disclosed. Palatine backed a major rollout of the company after investing £10m in the business from its £100m Impact fund in 2019. In the subsequent three years it increased the number of…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
.){kind=link}